A stepwise approach to the use of inhaled corticosteroids (ICS) for the management of bronchial asthma is recommended by all medical guidelines. However, often, ICS are used intermittently by patients, and/or recommended by physicians to be used during the onset of exacerbations. Hence, the present study was aimed to evaluate whither Libyan asthmatic patients are using ICS regularly or on demand, and their outcomes. The present study was conducted in Tripoli city, along a period of ten months, from May 2013 to February 2014. Three hundred patients of either sex recruited from different areas of Tripoli city; diagnosed with asthma and received treatment at Tripoli Medical Center and Abouseta Hospital were included in this study. The mean age of patients (± SD) was 51 years (± 29.1). Our results showed that 156 patients (52%)used ICS regularly(Male: 35% and female:65%), whereas, 48% (144 patients) used ICS during attack(Male; 35% and female: 65%). Of the total participants, 61% of patients stated that had asthmatic exacerbation symptoms within one month after discontinued ICS use (Male: 32% and female: 68%).Further more, 39% of patients reported experienced first exacerbation of symptom after 30 days of ceased ICS use (Male: 38% and female:62%).Exposure to cold, contact with dust and inhaler misuse were the most common reported cause of exacerbations, respectively by 71% (212 patients), 12% (37 patients) and 5% (15 patients).Our findings demonstrate that nearly halve of the Libyan asthmatic patients are using ICS on demand and few of them had experienced asthma exacerbations after ICS pause use. Hence, in order to reduce the long-term exposure to ICS and patients' cost, we suggest, in contrast to international standards of asthma care, use of ICS just during attacks as a new potential treatment option.